Biotech Values

[Biowatch]

CNBC will talk about new diabetes drugs, IMCL, etc. in next half hour.

Gottleib talked mainly about Gardasil in his appearance earlier.

Now he says FDA is developing new guidelines to make it clearer what the approval pathway should be for new diabetes drugs.

For cancer drugs, they are trying to streamline the process, and come up with new surrogate endpoints. e.g., PET scans to monitor lymphoma progress. They think colon cancer deaths will go down.